Showing results (1521-1530 of 1,765) with videos related to
Sort By:
Pageof 177
Neuroscience|March 11, 2025
Artificial intelligence in stroke rehabilitation: From acute care to long-term recoverySpandana Rajendra Kopalli, Madhu Shukla, B Jayaprakash, et al.Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|June 17, 2023
Impact of prostate radiotherapy on survival outcomes in clinically node-positive prostate cancer: A multicentre retrospective analysisThiraviyam Elumalai, Priyamvada Maitre, Robin Portner, et al.Drug Development Research|July 15, 2026
Discovery of a Potent and Selective MAO-B Inhibitor From a Donepezil-Linked Chalcone Library With Promising Antiparkinsonian ActivityAzize Kirac-Aydin, Bishnu Prasad Pandey, Satyajit Mohanty, et al.Oral Oncology|August 19, 2019
Nivolumab versus investigator's choice in patients with recurrent or metastatic squamous cell carcinoma of the head and neck: Efficacy and safety in CheckMate 141 by ageNabil F Saba, George Blumenschein, Joel Guigay, et al.Veterinary World|November 17, 2016
Infrared thermography: A potential noninvasive tool to monitor udder health status in dairy cowsM Sathiyabarathi, S Jeyakumar, A Manimaran, et al.Journal of Immunological Methods|August 7, 2019
Development of anti-chloro 192 tyrosine HDL apoA-I antibodies for the immunodiagnosis of cardiovascular diseasesKirubanandhan Lokeshwaran, Audrey Hemadou, N S Jayaprakash, et al.International Journal of Dermatology|May 19, 2018
Ertapenem - a potent treatment for clinical and quality of life improvement in patients with hidradenitis suppurativaTaylor L Braunberger, Nathan T Nartker, Cynthia L Nicholson, et al.Elife|January 30, 2024
SRF-deficient astrocytes provide neuroprotection in mouse models of excitotoxicity and neurodegenerationSurya Chandra Rao Thumu, Monika Jain, Sumitha Soman, et al.Cellular Signalling|April 28, 2026
Nobiletin reprograms cancer cell fate signaling: PI3K/Akt/mTOR-MAPK crosstalk, NF-κB/STAT3 inhibition and chemosensitizationAdithya Jayaprakash Kamath, Siva Syam, Gowri Rajesh, et al.Bioorganic Chemistry|December 3, 2014
Hydroxamates of para-aminobenzoic acid as selective inhibitors of HDAC8Umasankar Kulandaivelu, Laxmi Manasa Chilakamari, Surender Singh Jadav, et al.Pageof 177